Biontech Se (BNTX) SEC Filings — 2025
31 SEC filings for Biontech Se (BNTX) in 2025.
Filings
- BioNTech Completes CureVac Share Exchange Offer — 6-K · Dec 18, 2025
- Biontech Se 6-K Filing — 6-K · Dec 9, 2025
- BioNTech SE Files Form 6-K for December 2025 — 6-K · Dec 8, 2025
- Biontech Se 6-K Filing — 6-K · Dec 3, 2025
- Biontech Se 6-K Filing — 6-K · Nov 26, 2025
- BioNTech SE Hosts Innovation Series R&D Day — 6-K · Nov 12, 2025
- BioNTech SE Reports Q3 2025 Results — 6-K · Nov 3, 2025
- BioNTech Launches Exchange Offer for CureVac Shares — 6-K · Oct 22, 2025
- BioNTech Hosts Second AI Day with InstaDeep — 6-K · Oct 1, 2025
- BioNTech SE Enters Global Co-Development Deal — 6-K · Sep 8, 2025
- BioNTech SE Files Form 6-K for September 2025 — 6-K · Sep 5, 2025
- BioNTech/Pfizer COVID Vaccine Approved for Young Children — 6-K · Aug 27, 2025
- BioNTech SE Reports Ongoing Disputes with CureVac N.V. — 6-K · Aug 11, 2025
- BioNTech SE Reports Q2 2025 Financial Results — 6-K · Aug 4, 2025
- BioNTech/Pfizer Vaccine Gets EMA Nod for 2025-26 Season — 6-K · Jul 25, 2025
- BioNTech SE Announces CSO Ryan Richardson's Departure — 6-K · Jul 17, 2025
- BioNTech SE Files 6-K with Purchase Agreement Details — 6-K · Jun 17, 2025
- BioNTech SE Files Updated Articles of Association — 6-K · Jun 17, 2025
- BioNTech SE Enters Purchase Agreement with CureVac N.V. — 6-K · Jun 12, 2025
- BioNTech SE Announces Collaboration with Bristol Myers Squibb — 6-K · Jun 2, 2025
- BioNTech SE to Present Pipeline Clinical Trial Data — 6-K · May 27, 2025
- BioNTech Secures UK Government Grant for R&D Expansion — 6-K · May 20, 2025
- BioNTech SE Holds 2025 Annual General Meeting — 6-K · May 16, 2025
- BioNTech Appoints New CFO — 6-K · May 5, 2025
- BioNTech to Present Oncology Pipeline Data at AACR Meeting — 6-K · Apr 24, 2025
- BioNTech SE Announces 2025 Annual General Meeting Date — 6-K · Apr 4, 2025
- BioNTech SE Files Form 6-K with SEC — 6-K · Apr 2, 2025
- BioNTech SE Files 2024 Annual Report — 20-F · Mar 10, 2025
- BioNTech's BNT141 Vaccine Candidate Faces FDA Clinical Hold — 6-K · Mar 4, 2025
- BioNTech Acquires Biotheus to Boost Oncology Pipeline — 6-K · Feb 3, 2025
- BioNTech Outlines 2025 Strategy at J.P. Morgan Conference — 6-K · Jan 14, 2025